A citation-based method for searching scientific literature

Jacques Barbet, Loïc Campion, Françoise Kraeber-Bodéré, Jean-François Chatal. J Clin Endocrinol Metab 2005
Times Cited: 227







List of co-cited articles
842 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
69

Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
Anne Laure Giraudet, Abir Al Ghulzan, Anne Aupérin, Sophie Leboulleux, Ahmed Chehboun, Frédéric Troalen, Clarisse Dromain, Jean Lumbroso, Eric Baudin, Martin Schlumberger. Eur J Endocrinol 2008
150
47

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
877
35

Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Andreas Machens, Henning Dralle. J Clin Endocrinol Metab 2010
160
30

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
685
30

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
E Modigliani, R Cohen, J M Campos, B Conte-Devolx, B Maes, A Boneu, M Schlumberger, J C Bigorgne, P Dumontier, L Leclerc,[...]. Clin Endocrinol (Oxf) 1998
358
27

Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.
Johannes A A Meijer, Saskia le Cessie, Wilbert B van den Hout, Job Kievit, Johannes W Schoones, Johannes A Romijn, Johannes W A Smit. Clin Endocrinol (Oxf) 2010
95
26

Medullary thyroid cancer: management guidelines of the American Thyroid Association.
Richard T Kloos, Charis Eng, Douglas B Evans, Gary L Francis, Robert F Gagel, Hossein Gharib, Jeffrey F Moley, Furio Pacini, Matthew D Ringel, Martin Schlumberger,[...]. Thyroid 2009
823
25


Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.
A Miyauchi, T Onishi, S Morimoto, S Takai, F Matsuzuka, K Kuma, M Maeda, Y Kumahara. Ann Surg 1984
85
24

Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Andreas Machens, Ulrich Schneyer, Hans-Jürgen Holzhausen, Henning Dralle. J Clin Endocrinol Metab 2005
173
20

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008
327
19

Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Anne Laure Giraudet, Daniel Vanel, Sophie Leboulleux, Anne Aupérin, Clarisse Dromain, Linda Chami, Noël Ny Tovo, Jean Lumbroso, Nathalie Lassau, Guillaume Bonniaud,[...]. J Clin Endocrinol Metab 2007
150
17

Medullary thyroid carcinoma.
Sophie Leboulleux, Eric Baudin, Jean-Paul Travagli, Martin Schlumberger. Clin Endocrinol (Oxf) 2004
222
16


Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Andreas Machens, Jörg Ukkat, Steffen Hauptmann, Henning Dralle. Arch Surg 2007
68
22

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging.
G Pellegriti, S Leboulleux, E Baudin, N Bellon, C Scollo, J P Travagli, M Schlumberger. Br J Cancer 2003
88
17

Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Claudia Scollo, Eric Baudin, Jean-Paul Travagli, Bernard Caillou, Nicolas Bellon, Sophie Leboulleux, Martin Schlumberger. J Clin Endocrinol Metab 2003
231
15

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
15


Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Akira Miyauchi, Takumi Kudo, Akihiro Miya, Kaoru Kobayashi, Yasuhiro Ito, Yuuki Takamura, Takuya Higashiyama, Mitsuhiro Fukushima, Minoru Kihara, Hiroyuki Inoue,[...]. Thyroid 2011
161
14

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Rossella Elisei, Valeria Bottici, Fabiana Luchetti, Giancarlo Di Coscio, Cristina Romei, Lucia Grasso, Paolo Miccoli, Pietro Iacconi, Fulvio Basolo, Aldo Pinchera,[...]. J Clin Endocrinol Metab 2004
288
13

Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
Dana T Yip, Maria Hassan, Kalliopi Pazaitou-Panayiotou, Daniel T Ruan, Atul A Gawande, Randall D Gaz, Francis D Moore, Richard A Hodin, Antonia E Stephen, Peter M Sadow,[...]. Surgery 2011
37
32

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.
Nishant Agrawal, Yuchen Jiao, Mark Sausen, Rebecca Leary, Chetan Bettegowda, Nicholas J Roberts, Sheetal Bhan, Allen S Ho, Zubair Khan, Justin Bishop,[...]. J Clin Endocrinol Metab 2013
147
12

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
Martin J Schlumberger, Rossella Elisei, Lars Bastholt, Lori J Wirth, Renato G Martins, Laura D Locati, Barbara Jarzab, Furio Pacini, Chantal Daumerie, Jean-Pierre Droz,[...]. J Clin Oncol 2009
257
12

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Elaine T Lam, Matthew D Ringel, Richard T Kloos, Thomas W Prior, Michael V Knopp, Jiachao Liang, Steffen Sammet, Nathan C Hall, Paul E Wakely, Vasyl V Vasko,[...]. J Clin Oncol 2010
276
12

Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.
J B HAZARD, W A HAWK, G CRILE. J Clin Endocrinol Metab 1959
700
12

Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Hans H G Verbeek, John T M Plukker, Klaas Pieter Koopmans, Jan Willem B de Groot, Robert M W Hofstra, Anneke C Muller Kobold, Anouk N A van der Horst-Schrivers, Adrienne H Brouwers, Thera P Links. J Nucl Med 2012
59
20

Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
Reese W Randle, Courtney J Balentine, Glen E Leverson, Jeffrey A Havlena, Rebecca S Sippel, David F Schneider, Susan C Pitt. Surgery 2017
97
12


Determinants of life expectancy in medullary thyroid cancer: age does not matter.
Jan Willem B de Groot, John T M Plukker, Bruce H R Wolffenbuttel, Theo Wiggers, Willem J Sluiter, Thera P Links. Clin Endocrinol (Oxf) 2006
79
13

Chemoembolization for liver metastases from medullary thyroid carcinoma.
J Fromigué, T De Baere, E Baudin, C Dromain, S Leboulleux, M Schlumberger. J Clin Endocrinol Metab 2006
62
17

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
H Donis-Keller, S Dou, D Chi, K M Carlson, K Toshima, T C Lairmore, J R Howe, J F Moley, P Goodfellow, S A Wells. Hum Mol Genet 1993
11

Early malignant progression of hereditary medullary thyroid cancer.
Andreas Machens, Patricia Niccoli-Sire, Josef Hoegel, Karin Frank-Raue, Theo J van Vroonhoven, Hans-Dietrich Roeher, Robert A Wahl, Peter Lamesch, Friedhelm Raue, Bernard Conte-Devolx,[...]. N Engl J Med 2003
333
11

Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Giuseppe Costante, Domenico Meringolo, Cosimo Durante, Davide Bianchi, Maria Nocera, Salvatore Tumino, Umberto Crocetti, Marco Attard, Marianna Maranghi, Massimo Torlontano,[...]. J Clin Endocrinol Metab 2007
205
11

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
Samuel A Wells, Jessica E Gosnell, Robert F Gagel, Jeffrey Moley, David Pfister, Julie A Sosa, Michael Skinner, Annetta Krebs, James Vasselli, Martin Schlumberger. J Clin Oncol 2010
352
11

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
Samuel A Wells, Furio Pacini, Bruce G Robinson, Massimo Santoro. J Clin Endocrinol Metab 2013
184
11

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Martin Schlumberger, Barbara Jarzab, Maria E Cabanillas, Bruce Robinson, Furio Pacini, Douglas W Ball, Judith McCaffrey, Kate Newbold, Roger Allison, Renato G Martins,[...]. Clin Cancer Res 2016
138
11

Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
R Cohen, J M Campos, C Salaün, H M Heshmati, J L Kraimps, C Proye, E Sarfati, J F Henry, P Niccoli-Sire, E Modigliani. J Clin Endocrinol Metab 2000
163
10

Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
S Franc, P Niccoli-Sire, R Cohen, S Bardet, B Maes, A Murat, A Krivitzky, E Modigliani. Clin Endocrinol (Oxf) 2001
67
14

Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Kenko Cupisti, Achim Wolf, Andreas Raffel, Matthias Schott, Daniel Miersch, Qin Yang, Claus F Eisenberger, Hans D Röher, Wolfram T Knoefel. Ann Surg 2007
67
14

Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels.
Seng C Ong, Heiko Schöder, Snehal G Patel, Ida M Tabangay-Lim, Indukala Doddamane, Mithat Gönen, Ashok R Shaha, R Michael Tuttle, Jatin P Shah, Steven M Larson. J Nucl Med 2007
110
10

Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
Elizabeth Fox, Brigitte C Widemann, Meredith K Chuk, Leigh Marcus, Alberta Aikin, Patricia O Whitcomb, Maria J Merino, Maya Lodish, Eva Dombi, Seth M Steinberg,[...]. Clin Cancer Res 2013
96
10

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Razelle Kurzrock, Steven I Sherman, Douglas W Ball, Arlene A Forastiere, Roger B Cohen, Ranee Mehra, David G Pfister, Ezra E W Cohen, Linda Janisch, Forlisa Nauling,[...]. J Clin Oncol 2011
416
10

Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon.
A Boichard, L Croux, A Al Ghuzlan, S Broutin, C Dupuy, S Leboulleux, M Schlumberger, J M Bidart, L Lacroix. J Clin Endocrinol Metab 2012
91
10

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.
Raffaele Ciampi, Caterina Mian, Laura Fugazzola, Barbara Cosci, Cristina Romei, Susi Barollo, Valentina Cirello, Valeria Bottici, Giulia Marconcini, Pelizzo Maria Rosa,[...]. Thyroid 2013
109
10

Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial.
Fabienne Iten, Beat Müller, Christian Schindler, Christoph Rochlitz, Daniel Oertli, Helmut R Mäcke, Jan Müller-Brand, Martin A Walter. Clin Cancer Res 2007
97
10

Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
M R Pelizzo, I M Boschin, P Bernante, A Toniato, A Piotto, C Pagetta, O Nibale, L Rampin, P C Muzzio, D Rubello. Eur J Surg Oncol 2007
133
10

The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Nazanene H Esfandiari, David T Hughes, Huiying Yin, Mousumi Banerjee, Megan R Haymart. J Clin Endocrinol Metab 2014
54
18

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.